Why go beyond the standard of care?

All of us in the field — scientists, oncologists, surgeons, clinicians – must acknowledge the standard of care is not saving enough lives. The field of precision medicine; specifically, Live Tissue Science, however, can change the landscape of cancer treatment. Let us connect you to personalized research for your clinical benefit. It will differentiate your practice, placing it on the forefront of offering targeted cancer treatment options for your patients. By partnering with SpeciCare, you will have easy access to tissue storage for your patients’ care plans. This opens the doors to hundreds of new treatment options, changing the future possibilities for you patients.


Patient diagnosed with solid tumor cancer


Tumor tissue harvested and cryopreserved viably


Provides access to precision cancer treatment


Results create options beyond standard of care

Currently, only three percent of patients are placed in clinical trials. While the individual patient may benefit from participation, the ultimate purpose of that clinical trial is to create new treatment options for the patient of the future. We hope individualizing clinical trial participation and returning information back to the patient will help shift research to focus more on the patients of today. This will also allow the 85% of patients being treated in their local community access to leading-edge solutions that transcend geographic boundaries.



of cancer patients are placed on clinical trials



of cancer patients receive cancer care in their local communities



of cancer patients are places on clinical trials


of cancer patients receive cancer care in their local communities

Storing Your Patient’s Tissue

Storing living tumor tissue gives patients NEW options
Tumor tissue usage has traditionally been used for drug discovery and basic research until recently. SpeciCare is leading the way in bringing together individual research and precision cancer care delivery by collecting, processing and storing patients’ viable and fixed tumor tissue for all types of cancers in multiple formats including:

Cryopreserved Dissociated Cells



With our lab-proven SpeciKit® collection kit, we help you preserve your patient’s tissue at the time of surgery or biopsy. We will obtain all legal documentation from your patient to take control of his or her living tumor tissue and provide the SpeciKit® for use the day of surgery. The kit includes easy instructions for tissue collection as well as a pre-paid postage for easy delivery back to SpeciCare.

Upon receipt of your patient’s tissue, the pathology laboratory will process the tissue to confirm percent necrosis, percent viable tumor and document the number of aliquots of viable dissociated tissue and the number of vials of chunk tissue that were successfully collected and preserved for physician and patient directed use.

We help you create new treatment opportunities and clinically actionable research information in the treatment of your patients.

“Our Individual Precision Medicine process developed with SpeciCare takes living tissue from the patient to preserve in several formats, thereby maximizing opportunities for its use for the patient’s benefit. This biological material is preserved using advanced cryopreservation methods that are consistent with industry-leading biorepositories and in vitro fertilization clinics worldwide. All tissue is reviewed by ASCP-certified Cytotechnologists and Pathologists to document its content and quality.

We are pleased with this medical advancement because it empowers the patient to take part in their own outcomes. By preserving cells and tissue from the patient and giving them ownership, they become an active participant in the treatment process. Together with SpeciCare, we believe by increasing the availability of high-quality specimens, cancer treatment can evolve to a more informed and targeted process at the individual level.”

Dr. Carol C. Eisenhut MD, MBA, President, DCL Pathology, SpeciCare Partner

Patient Benefits

Benefits to storing living tumor tissue


Storing tumor tissue opens the door to significant opportunities for long-term survival, including creating access to researchers, clinical trials, ex vivo therapy testing, clinical vaccines, organoid creation and more. More than half of patients who store their tumor tissue utilize a portion within the first year, creating access to new options that can be delivered locally with the patient’s own clinical care team.
Learn more


When time matters most, you want to be close to family and friends. With SpeciCare, we can send the tumor in your place as part of a result-directed treatment program and clinical recommendations administered by your local care team.


Organoid creation, access to clinical trials, genetic sequencing, individualized vaccine, tumor-infiltrating lymphocytes (TILs), chemo-sensitivity testing, and other precision medicine treatment options can help quickly pinpoint a treatment regimen right for you without unnecessary side effects and trial and error.


Science and medicine have come a long way in recent years. With Live Tissue Science™ we can advance treatment success rates from 10% to more than 70% … today.

Options with Live Tissue Science


We know that feeling as good as possible during treatment is important. Your tissue gives you the opportunity to test your body’s sensitivity to certain kinds of chemotherapy even before you begin treatment. It can also help clinicians evaluate effectiveness prior to administering it to you to guide their chemo choices and save valuable time when time matters most.


Cancer is a genetic disease that is caused by changes in the DNA that change the way cells function. By testing your unique combination of genetic changes and tumor DNA sequencing, researchers can help provide information to your medical team that can aid in their treatment planning. Knowledge of your specific genetic mutation profile helps especially in identifying targeted therapies and finding precise options showing the most promise for your genetic make-up.


Participating in clinical trials can be a good way to gain access to some of the latest treatment options before they become standard of care. By having frozen tumor tissue available, the researchers may be able to test the response of your tumor with their trial before testing it on you. In addition, many clinical trials pursue participants with live tumor tissue samples to aid in their research, so by having it available you increase the options available to you.


Your tumor tissue can be used to create a vaccine that is personal to your cancer, body and immune system. The vaccine will allow your body to recognize the cancer cells so it can more effectively fight them while stimulating your immune system.


A newly emerging field in precision medicine is the use of patient-derived cancer tissue that is grown into ‘organoids’ (3D cultures of cancerous cells) in the laboratory which can be used for large-scale drug screening, fundamental cancer biology research, oncogene modeling, gene discovery and chemo-sensitivity studies.

Physician Resources

Patient Advocates

SpeciCare collects, tests and preserves live tumor tissue for all types of cancers for physician and patient-directed use to create new treatment opportunities and clinically actionable research information back to our patients.

Talking points for your patient

Our FAQs include common questions about tissue banking, SpeciCare and potential uses for tumor tissue that you may encounter in your discussions with your patient.

Patient Information

We believe knowledge is power, which is why we have created patient brochures for your office to help guide the conversation and answer questions so that your patient can carefully consider if tumor banking is right for them.

Educational Sessions

Learn from our experts about the evolving field of precision medicine and about our SpeciCare process and how the availability of tumor tissue opens the doors to personalized cancer care for your patients. Contact us at 1-833-242-2873 to schedule today.

A Note From Our Founder

For more than 35 years, Ken Dixon, M.D., FACS, a surgeon with Surgical Oncology of Northeast Georgia, has treated cancer patients in his practice located in Gainesville, Ga. After a lifetime taking care of cancer patients, and telling a patient or a family member ‘there is nothing left to do’ Dr. Dixon began a journey to do more.
For more than 35 years, Ken Dixon, M.D., FACS, a surgeon with Surgical Oncology of Northeast Georgia, has treated cancer patients in his practice located in Gainesville, Ga. After a lifetime taking care of cancer patients, and telling a patient or a family member ‘there is nothing left to do’ Dr. Dixon began a journey to do more.